Dashan Yin

Dr. Dashan Yin

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2025 in Current Oncology
Verified
Journal Article
Open access
PDF file
DYDashan Yin
Dashan Yin
XHXiujuan Hong
Xiujuan Hong
XWXiaoqi Wang
Xiaoqi Wang
WDWenjia Ding
Wenjia Ding
CWChenli Wang
Chenli Wang
ZWZhibing Wu
Zhibing Wu
Patient-derived organoids (PDOs) preserve patient genotypes and 3D architecture, offering a useful platform to investigate mechanisms of radioresistance and test radiosensitizers. We outline an end-to-end workflow—model establishment, multi-omics profiling, pharmacologic screening, and in vivo confirmation—and spotlight immune-competent, vascularized, and organ-on-chip formats. PDOs reveal actionable mechanisms across DNA damage response, hypoxia–metabolic and immune remodeling, and radiation-induced senescence, enabling rational radiosensitizer selection. Paired tumor–normal organoids concurrently gauge efficacy and normal tissue toxicity, refining the therapeutic index. Remaining gaps (incomplete microenvironment, fractionation modeling, and standardization) are being addressed via reporting standards and co-clinical studies, positioning PDOs to support precision radiotherapy.

31 August 2026 in Materials Today Bio
Verified
Journal Article
Open access
XHXiujuan Hong
Xiujuan Hong
XWXiaoqi Wang
Xiaoqi Wang
WWWankun Wang
Wankun Wang
WRWeiye Ren
Weiye Ren
WDWenjia Ding
Wenjia Ding
ZWZhibing Wu
Zhibing Wu